|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.71 CNY | +3.43% |
|
+5.47% | +21.34% |
| 07-13 | ApicHope Pharmaceutical Receives Shareholder Proposal from Hanxiong Li | CI |
| 06-11 | China Approves ApicHope Subsidiary's Clinical Trials for Leukemia Drug | MT |
| Market Cap | 18.26B 2.7B 2.36B 2.18B 2.01B 3.79B 260B 3.87B 26.04B 10.2B 127B 10.14B 9.92B 438B | P/E 2026 * |
35.1x | P/E 2027 * | -177x |
|---|---|---|---|---|---|
| Enterprise Value | 18.26B 2.7B 2.36B 2.18B 2.01B 3.79B 260B 3.87B 26.04B 10.2B 127B 10.14B 9.92B 438B | EV / Sales 2026 * |
16.9x | EV / Sales 2027 * | 14.5x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.43% | ||
| 1 week | +5.47% | ||
| Current month | +9.20% | ||
| 1 month | +16.08% | ||
| 3 months | +14.74% | ||
| 6 months | -2.49% | ||
| Current year | +21.34% |
| 1 week | 36.5 |  | 41 |
| 1 month | 31.37 | | 44.8 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 81.48 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
Liang Wen Huang
CHM | Chairman | 50 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-05 | Buy | Director | 4,200 | 0.0010% | ||
| 11-24 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.43% | +5.47% | -24.29% | +45.65% | 2.6B | |
| +1.10% | +2.06% | +15.45% | +81.05% | 48.17B | |
| +0.36% | -4.47% | +66.16% | +115.81% | 35.47B | |
| +0.80% | -0.94% | -3.09% | +39.50% | 12.04B | |
| +0.20% | -1.68% | +17.05% | +90.41% | 11.79B | |
| +1.53% | +0.38% | +32.83% | +126.50% | 9.15B | |
| +1.09% | -2.04% | +18.52% | +37.49% | 6.91B | |
| +1.33% | -1.06% | +48.46% | -4.10% | 6.95B | |
| +0.17% | +1.77% | +3.87% | +228.32% | 6.79B | |
| +3.56% | -6.15% | -20.01% | +13.39% | 5.77B | |
| Average | +1.36% | -0.48% | +15.50% | +77.40% | 14.56B | |
| Weighted average by Cap. | +0.96% | -1.71% | +26.56% | +87.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 160M 140M 129M 119M 224M 15.36B 229M 1.54B 603M 7.49B 600M 587M 25.91B | 1.26B 186M 163M 150M 139M 261M 17.89B 267M 1.79B 703M 8.73B 699M 683M 30.18B |
| Net income | 526M 77.78M 67.98M 62.84M 57.97M 109M 7.48B 112M 750M 294M 3.65B 292M 286M 12.62B | -102M -15.08M -13.18M -12.19M -11.24M -21.17M -1.45B -21.63M -145M -56.96M -708M -56.65M -55.4M -2.45B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | CN¥40.71 | +3.43% | 19,727,349 |
| 13/07/26 | CN¥39.36 | -0.98% | 18,154,135 |
| 10/07/26 | CN¥39.75 | +5.05% | 20,104,880 |
| 09/07/26 | CN¥37.84 | +0.40% | 14,805,164 |
| 08/07/26 | CN¥37.69 | -2.36% | 13,893,809 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
